Blood type distribution differs substantially across racial and ethnic groups, shaped by thousands of years of migration, genetic drift, and natural selection. In the United States, for example, group O is the most common type in Hispanic, Black, and Native American populations, while group A narrowly edges out O among white non-Hispanic Americans. Those differences extend well beyond the familiar A-B-O system into dozens of lesser-known blood group antigens that can vary even more dramatically by ancestry, with real consequences for transfusion safety and pregnancy care.
How ABO Types Break Down by Race and Ethnicity
The largest U.S. study of blood-type frequencies by race analyzed data from the American Red Cross and found stark patterns. Among Hispanic donors, group O accounted for about 57% of the population. Native American donors were close behind at roughly 55% group O. Black non-Hispanic donors also leaned heavily toward O at about 50%. White non-Hispanic donors, by contrast, split more evenly between O and A, with A slightly more common. Asian donors showed the highest proportion of group B among the groups studied.1PubMed. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States
These patterns are not unique to the United States. A large population-based study in China found significant variation across nine ethnic groups within a single country. The Zhuang group had the highest proportion of O phenotypes at about 42%, while the Yi group had the most A phenotypes at 34%. The Manchu and Mongolian groups had unusually high rates of group B, above 33%.2PubMed. Frequencies and ethnic distribution of ABO and RhD blood groups in China: a population-based cross-sectional study The takeaway is that blood-type variation is not just a broad continental pattern. Even neighboring populations within the same country can have meaningfully different distributions.
The Rh Factor Gap
The Rh system, particularly the D antigen that determines whether someone is “positive” or “negative,” shows one of the most pronounced ethnic differences of any blood group. About 17% of white non-Hispanic donors in the U.S. are Rh-negative, compared to roughly 7% of Hispanic and Black non-Hispanic donors and an even smaller fraction of Asian donors.1PubMed. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States This means that O-negative blood, the so-called universal donor type, is far more available in predominantly white donor pools and considerably rarer in others. Among white non-Hispanic donors, about 8% are O-negative. That figure drops to around 4% in Hispanic donors, about 4% in Black non-Hispanic donors, and below 1% in Asian donors.
The practical implication is straightforward: trauma centers and emergency departments that serve diverse populations cannot assume their general blood supply will have enough Rh-negative units for everyone who needs them. The mismatch becomes especially important in regions where the donor base does not reflect the patient population.
Why Blood Types Differ Across Populations
The global patchwork of blood types reflects a combination of ancient migration, random genetic drift in small founding populations, and natural selection driven by infectious disease. The relative weight of each factor has been debated for nearly a century.3PubMed. The relationship between blood groups and disease Environmental pressures like disease, climate, and altitude all play a role in shaping which blood-type alleles become common in a given region.4PubMed Central. A brief history of human blood groups
For the ABO system specifically, modeling work has pointed to two complementary selective pressures. Bacteria that colonize mucosal surfaces tend to adapt to the most common host blood-type antigens in a population, creating an advantage for people who carry rarer types. Meanwhile, viruses that pick up blood-type molecules from their previous host’s cells face a harder time infecting hosts with a different blood type, because those hosts carry antibodies against the mismatched antigens. Together, these two forces can maintain all three ABO alleles in a population rather than letting one sweep to dominance.5PubMed Central. Evolution of the human ABO polymorphism by two complementary selective pressures
Genetic drift and founder effects explain some of the more extreme distributions. Native American populations, for instance, have unusually high frequencies of group O, and research has shown that much of this is attributable to the small founding populations that first migrated into the Americas and the genetic bottlenecks they passed through along the way. Statistical analysis found no significant ABO differences among Mesoamerican and South American groups, but substantial variation within groups that traced to drift and founder effects.6PubMed. Blood group O alleles in Native Americans: implications in the peopling of the Americas
The Duffy System and Protection Against Malaria
One of the most dramatic examples of natural selection shaping a blood group by ethnicity is the Duffy system. The Duffy antigen on red blood cells serves as a receptor for the malaria parasite Plasmodium vivax, which uses it to invade red cells. People who lack both Duffy antigens, a phenotype called Duffy-negative, are resistant to this form of malaria.7PubMed. Duffy blood group and malaria
In West and Central Africa, where P. vivax historically posed a severe threat, the Duffy-negative phenotype has been driven to near-fixation. Mapping studies show that across more than 30 sub-Saharan African countries, the frequency of the silent Duffy allele exceeds 90%, and in parts of West, Central, and East Africa it reaches 100%, meaning virtually everyone in those areas is Duffy-negative.8Nature Communications. The global distribution of the Duffy blood group By contrast, the Duffy-negative phenotype is essentially absent in European and most Asian populations. This is one of the clearest cases of a blood group antigen being sculpted by a single infectious disease over millennia.
The story has a twist, though. Researchers have documented P. vivax infections in Duffy-negative individuals in parts of Africa and South America, suggesting the parasite may be evolving alternative entry routes into red cells.9PubMed Central. Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation? Whether this represents a genuine new adaptation or cases that went undetected in the past is still being investigated, but either way it complicates the long-held assumption that Duffy-negative status provides absolute protection.
Other Blood Group Systems That Vary by Ancestry
Beyond ABO, Rh, and Duffy, dozens of blood group systems show ethnic variation. These rarely make headlines, but they matter when patients need repeated transfusions or when a pregnant person carries antibodies against fetal red cell antigens. A few examples stand out.
The Diego system carries an antigen found almost exclusively in East Asian and Indigenous American populations. In Malaysia, the Di(a) antigen was present in about 4% of Chinese donors and 1.2% of Malay donors, but under 1% of Indian donors.10PubMed Central. Prevalence of Diego blood group antigen and the antibody in three ethnic population groups in Klang valley of Malaysia In the Americas, the Diego A allele reaches high frequencies in Andean and Amazonian populations but is essentially absent in Arctic and some other groups, tracing the migration and divergence of Indigenous peoples across the continents.11PubMed Central. Revisiting the Diego Blood Group System in Amerindians: Evidence for Gene-Culture Comigration The antigen is virtually nonexistent in European and African populations.
The Kell system shows subtler but clinically important variation. In Indian blood donors, the frequency of the Kell antigen (K) was about 3.5%, placing it between the rates reported for Caucasian populations (around 9%) and Black populations (around 2%). The Duffy system in Indian donors was also distinctive, with neither the pattern seen in European populations nor the widespread Duffy-negative phenotype seen in African-descent populations. Only 0.3% of Indian donors were Duffy-negative, compared to 68% of Black donors. The Kidd system similarly showed Indian frequencies closer to Caucasian and Chinese patterns than to those of Black populations.12PubMed Central. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population
These differences matter most in transfusion medicine, where mismatches in minor antigens can trigger immune reactions that make future transfusions difficult or dangerous.
Transfusion Risk When Donor and Patient Ancestry Differ
For patients who need occasional transfusions, the standard ABO and Rh matching is usually enough. But for people who require chronic transfusions, the mismatch between their extended blood-type profile and the typical donor pool becomes a serious medical problem. Sickle cell disease offers the starkest illustration.
Sickle cell disease primarily affects people of African descent, and these patients often require regular blood transfusions throughout their lives. Because most blood donors in Western countries are of European descent, the red cells these patients receive frequently carry antigens that differ from their own. A landmark study in the New England Journal of Medicine found that 30% of sickle cell patients became alloimmunized, meaning their immune systems developed antibodies against donor blood, compared to just 5% of patients with other forms of anemia who received similar volumes of blood. Antibodies against the K, E, C, and Jk(b) antigens accounted for 82% of the problem. The researchers concluded that racial differences between the donor and recipient populations were a major driver.13PubMed. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood
Minority populations who need chronic transfusions face a particularly high risk of this kind of immune reaction when the donor pool does not share their ancestral background, simply because the mismatch in minor antigens is larger.14PubMed Central. Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors The solution is extended antigen matching: typing donor blood for antigens beyond ABO and Rh and selecting units that match the patient’s broader profile. When this is combined with selecting donors from racially similar populations, patients are exposed to roughly 1.6 non-self antigens per transfusion, compared to about 3.5 when using a general donor inventory.15Blood Red Cells & Iron. Red cell antigen exposures in patients with sickle cell disease receiving transfusion from Black and Hispanic donors
Molecular-level matching has yielded clear clinical benefits for sickle cell patients, including higher post-transfusion hemoglobin levels, lower percentages of sickle hemoglobin, and fewer transfusion reactions.16PubMed Central. Optimized Antigen-Matched in Sickle Cell Disease Patients: Chances and Challenges in Molecular Times – the Brazilian Way Early advocates recommended that any transfusion center managing chronically transfused sickle cell patients adopt extended matching, not just to prevent alloimmunization but because the broader clinical benefits justify the additional cost.17PubMed. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease
The Challenge of Recruiting Ethnically Matched Donors
If the best solution for at-risk patients is antigen-matched blood from donors who share their ancestry, the obvious next question is whether enough of those donors exist. In many countries, the answer is not yet. Blood donor pools tend to underrepresent ethnic and racial minorities, creating a supply gap for patients who need extended matching.
A systematic review of interventions designed to increase blood donation among minority groups found that the problem is solvable. All eight intervention studies reviewed reported positive outcomes, with seven finding that the intervention increased the number of people who showed up to donate, and three finding an increase in the percentage of new donors from the targeted minority group.18PubMed Central. Interventions to Increase Blood Donation among Ethnic/Racial Minorities: A Systematic Review
Research into what motivates minority donors points to trust in individuals as a key predictor of willingness to donate. The concept of conditional cooperation, where seeing someone in your social network donate makes you more likely to do so yourself, appears to be a powerful lever. Social media posts about having just donated, or visible donation-status icons on platforms, can trigger this effect in communities where institutional trust in blood services may be lower.19PubMed Central. Trust and distrust: Identifying recruitment targets for ethnic minority blood donors The gap is less about unwillingness and more about access, awareness, and the feeling that donation systems were not designed with minority communities in mind.
Rare Types and Isolated Populations
Some blood type challenges go beyond common ABO and Rh mismatches and into truly rare territory. Small or isolated populations can harbor blood-type profiles that barely exist elsewhere. Among semi-nomadic Bedouin communities in southern Israel, for instance, the Jr(a-negative) phenotype creates a supply crisis because almost no one outside the community carries compatible blood. Researchers have described this as a health equity challenge that disproportionately affects marginalized groups who already face barriers to care.20PubMed Central. Rare blood, rare voices: a participatory approach to advancing transfusion equity in the Bedouin community
This kind of situation is more common than you might expect. Genetic drift in small founding populations can push unusual alleles to high frequencies within a community while leaving them virtually absent in surrounding groups. The result is pockets of blood-type rarity scattered around the world, each posing a localized but potentially life-threatening problem when someone in that community needs a transfusion.
Pregnancy Complications Tied to Rh Differences
The ethnic distribution of Rh-negative blood also matters in obstetrics. When an Rh-negative mother carries an Rh-positive fetus, her immune system can develop antibodies against the baby’s red blood cells, a condition that can cause hemolytic disease of the newborn. Preventive treatment with Rh immunoglobulin (commonly known by the brand name RhoGAM) is standard in much of the developed world, but in populations where Rh-negative status is rarer, awareness and screening can lag behind.
A study in southern Ethiopia found that among neonates born to Rh-negative women who had previously delivered, a quarter were affected by jaundice.21PubMed Central. Rhesus Negativity Prevalence and Neonatal Outcomes among Pregnant Women Delivered at Bule Hora University Teaching Hospital, West Guji Zone, South Ethiopia In predominantly Rh-positive populations, where only a small percentage of pregnancies involve Rh incompatibility, the condition can be overlooked precisely because it is uncommon. A Chinese study of 100 Rh-negative pregnancies found that outcomes varied by ethnicity even within the study group, with certain minority ethnic groups experiencing a higher incidence of fetal distress than Han and Zhuang mothers.22PubMed Central. Analysis of pregnancy and neonatal outcomes in 100 pregnant women with Rh-negative blood type
The broader point is that being Rh-negative in a population where most people are Rh-positive creates a double disadvantage: the condition is more likely to cause complications when it is not anticipated, and compatible blood for emergency transfusion is harder to find.
Blood Type and Disease Susceptibility
The connection between blood type, ethnicity, and health goes beyond transfusion compatibility. ABO type has been linked to differences in risk for several non-infectious diseases, with non-O blood groups consistently showing higher rates of blood clots. A study examining venous thromboembolism found that clot rates were higher in Black individuals and in people with non-O blood types across all age groups studied.23PubMed Central. Race, ABO blood group, and venous thromboembolism risk: not black and white Since ABO distribution varies by race, and clot risk varies by both ABO type and race independently, disentangling which factor drives what portion of the risk is an active area of research. The title of that paper captures the challenge well: the interaction between race, blood group, and clotting risk is genuinely not straightforward.
Similar patterns have been reported for cardiovascular disease, certain cancers, and susceptibility to specific infections, though the effect sizes for most conditions are modest. Knowing your ABO type is not a reason to panic about any particular disease, but it is one more piece of biological context that physicians can factor in when assessing risk, particularly for patients from populations with distinctive blood-type profiles.
Organ Transplantation and the Donor Gap
The mismatch between who needs medical treatment and who is available to provide biological material extends beyond blood transfusion to organ transplantation. ABO compatibility is a requirement for most organ transplants, and the ethnic composition of donor registries rarely mirrors the patient waiting list. In the UK, one analysis found that while South Asian patients made up about 14% of the transplant waiting list, fewer than 2% of deceased organ donors were South Asian. Refusal rates from relatives for deceased donation were also far higher among Asian families than among Caucasian families. Living donation partially offset this gap, with about 7% of living donors being Asian, but the overall disparity remained stark.
Blood-type distributions help explain part of this waiting-list imbalance. If a population has a distinctive ABO profile and is underrepresented in the donor pool, compatible organs simply appear less frequently. Combined with cultural and religious hesitations around organ donation, the result is longer wait times and worse outcomes for minority patients who need transplants. Addressing this requires both targeted community engagement and policy changes that make donation accessible and culturally appropriate for underrepresented groups.